share_log

华纳药厂:子公司原料药富马酸伏诺拉生获得上市申请批准通知书

Warner Pharmaceuticals: The subsidiary's Active Pharmaceutical Ingredient, Fumaric Acid Vinylamine, has received the approval notice for its listing application.

Breakings ·  Mar 16 07:37

Warner Pharmaceutical (688799.SH) announced that its wholly-owned subsidiary Hunan Warner D pharmaceutical Co., Ltd. has received the Approval Notice for the Application for Listing of Chemical Raw Materials for Fumaric Acid Vornorphan from the National Medical Products Administration, which has been publicized on the platform of the National Medical Products Administration Drug Review Center. This Active Pharmaceutical Ingredient has met the relevant national pharmaceutical review technical standards and has been approved for use in domestic formulations, which will further enrich the company's product line and enhance the company's core competitiveness.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 317

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.